If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.15    0.00 (0.00%)
Bid:
1.10
Ask:
1.20
Spread: 0.10 (9.091%)
Market Cap: £9.84m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Tern PLC: Director appointment

31 Mar 2020 07:00

Tern PLC (TERN) Tern PLC: Director appointment 31-March-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


31 March 2020

 

Tern Plc ("Tern" or the "Company")

Director appointment

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce the appointment of Matthew Scherba as Investment Director with immediate effect.  Matthew originally joined Tern in December 2019 in a non-Main Board capacity.

Matthew has 25 years of start-up and scale-up experience specialising in working and investing in technology companies across the IoT industry, his experience covers the full company lifecycle development, from start-up to exit, with a focus on strategy and commercial scale across both the private and public sector markets. Prior to joining Tern, he spent almost five years at a UK venture capital investment company dedicated to the IoT arena. During this time, he helped originate, invest and support the development of disruptive technology companies in the UK, Europe and the US, and particularly within artificial intelligence (AI) and machine learning. Additionally, he held board positions on several portfolio companies, and worked with management teams to help develop their strategic, commercial and operational functions.

Al Sisto, CEO of Tern, said:

"With 25 years of experience working with or investing in technology companies, Matthew will be a highly valuable addition to our Board. He has already made a significant contribution since joining our company at the end of 2019 and we look forward to benefitting from his experience at a Board level. As Investment Director, he will help us to expand our support to our portfolio companies, identify commercial businesses and new opportunities in this high growth industry and further develop our investment strategy."

 

 

Matthew Peter Scherba (aged 53)

In accordance with Schedule 2(g) of the AIM Rules, Matthew Scherba holds, or has held in the past five years, the following directorships and partnerships: 

Current

Past five years

Tx3 Solutions Limited

Wearable Technologies LimitedTalepathy Limited

Plancentric Limited

Foodmarble Digestive Health Limited (Ireland)

Plancentric Global Limited

Peafowl Solar Power AB

Foodmarble Digestive Health Limited (UK)

 

InVMA Limited

 

 

Mr Scherba and his family members are beneficially interested in a total of 716,0001 ordinary shares of 0.02p in Tern ("Ordinary Shares"), which is equivalent to 0.25% of the Company's voting rights.

1Mr Scherba is beneficially interested in 325,000 Ordinary Shares and his family members are beneficially interested in the following Ordinary Shares: L Gennard, 325,000 Ordinary Shares, L Scherba, 33,000 Ordinary Shares and S Scherba, 33,000 Ordinary Shares.

 

Enquiries

 

Tern Plc

Al Sisto/Sarah Payne

via Newgate Communications

 

Allenby Capital Limited

(Nomad and Joint broker)

David Worlidge/Alex Brearley/Guy McDougall

 

Tel: 0203 328 5656

 

Whitman Howard

(Joint broker)

Nick Lovering/Christopher Furness

 

Tel: 020 7659 1234

 

Newgate Communications

Elisabeth Cowell/Megan Kovach

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCM
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:55537
EQS News ID:1011119
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
16th Mar 20222:01 pmRNSPrice Monitoring Extension
16th Mar 20227:01 amRNSSVV Fund investment in RETìníZE
10th Mar 20227:00 amRNSWyld Networks Purchase Orders
2nd Mar 20227:00 amRNSParticipation in SVV UK Software Technology Fund
22nd Feb 20223:09 pmRNSDevice Authority Agreement with Avnet
11th Feb 20227:00 amRNSPortfolio Update
1st Feb 20227:00 amRNSTalking Medicines Fund Raise
11th Jan 20221:45 pmRNSWyld Networks Connectivity Partnership
31st Dec 202112:30 pmRNSTotal Voting Rights
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Dec 202112:30 pmRNSChange in Wyld Networks Shareholding
20th Dec 20217:00 amRNSInVMA Fund Raise and Update
15th Dec 20213:04 pmRNSExercise of Options
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:36 pmRNSPrice Monitoring Extension
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension
8th Dec 20219:00 amRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
3rd Dec 20219:00 amRNSPrice Monitoring Extension
2nd Dec 20214:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20214:35 pmRNSPrice Monitoring Extension
2nd Dec 20212:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
2nd Dec 202110:01 amRNSDevice Authority Strategic Investment & Funding
1st Dec 20217:00 amRNSDevice Authority convertible loan notes
26th Oct 20217:00 amRNSPortfolio Update
20th Sep 20217:30 amRNSWyld purchase order from Bayer Crop Science
16th Sep 20217:00 amRNSInvestor webinar recording
14th Sep 20217:00 amRNSInterim Results
3rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20214:35 pmRNSPrice Monitoring Extension
3rd Sep 20212:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20212:00 pmRNSPrice Monitoring Extension
3rd Sep 202111:05 amRNSSecond Price Monitoring Extn
3rd Sep 202111:00 amRNSPrice Monitoring Extension
25th Aug 20217:00 amRNSWyld Networks Third Party Funding
17th Aug 20217:00 amRNSInvestment in FundamentalVR and Portfolio Update
4th Aug 20214:41 pmRNSSecond Price Monitoring Extn
4th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20212:06 pmRNSSecond Price Monitoring Extn
4th Aug 20212:00 pmRNSPrice Monitoring Extension
30th Jul 20215:18 pmRNSTotal Voting Rights
14th Jul 20217:00 amRNSResult of Fundraise
13th Jul 20215:07 pmRNSRetail Offer
13th Jul 20215:05 pmRNSEquity Fundraise of up to £4 million
2nd Jul 20218:05 amRNSWyld Networks - Trading on NASDAQ First North
28th Jun 202110:00 amRNSWyld Networks IPO Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.